DopaCell

N/A

Report date: 2026/05/08 20:02:52

Base Information

Drug NameDopaCell

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Source of cells > Embryonic stem cell-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Dopamine progenitor cell

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsParkinson Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIran

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesRoyan AtiTech Pharmed

China Registration ClassN/A

Develop Information

Active CompaniesRoyan AtiTech Pharmed Royan Institute

Inactive CompaniesN/A

Active IndicationsParkinson Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A